AbbVie Inc.
ANTI-EGFR ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Last updated:
Abstract:
The invention relates to anti-epidermal growth factor (EGFR) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
Status:
Application
Type:
Utility
Filling date:
7 Feb 2020
Issue date:
31 Dec 2020